Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis

Commons, R. J., Grivas, R. and Currie, Bart J. (2014). Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis. Internal Medicine Journal,44(12a):1245-1246.

Document type: Journal Article
Citation counts:
Google Scholar Search Google Scholar

IRMA ID 75039815xPUB673
Title Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis
Author Commons, R. J.
Grivas, R.
Currie, Bart J.
Journal Name Internal Medicine Journal
Publication Date 2014
Volume Number 44
Issue Number 12a
ISSN 1444-0903   (check CDU catalogue open catalogue search in new window)
Scopus ID 2-s2.0-84912138590
Start Page 1245
End Page 1246
Total Pages 2
Place of Publication Australia
Publisher Wiley-Blackwell Publishing Asia
HERDC Category C1 - Journal Article (DIISR)
Abstract Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei and can present with severe sepsis. Predisposing risk factors are present in 80% of cases. Monoclonal antibodies are increasingly prescribed for varied medical conditions. This report describes the first known case of melioidosis in a patient whose only risk factor for disease is treatment with a monoclonal antibody. Prescribers of monoclonal antibodies and other immunosuppressants should ensure that their patients are aware of the potential risk of melioidosis prior to travel and the precautions that should be taken.
Keywords Burkholderia pseudomallei
monoclonal antibody
melioidosis
psoriatic arthritis
immunosuppression
DOI http://dx.doi.org/10.1111/imj.12610   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
 
Versions
Version Filter Type
Access Statistics: 17 Abstract Views  -  Detailed Statistics
Created: Wed, 19 Aug 2015, 12:18:54 CST